Lapatinib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3650 publications
EGFR INHIBITION PROMOTES ENTEROENDOCRINE CELL DIFFERENTIATION CONTRIBUTING TO TREATMENT-ASSOCIATED DIARRHEA.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Computational Drug Repurposing Predicts FDA-Approved Drugs as Potential Inhibitors of Chikungunya Virus nsP2 Protease.
Journal: The journal of physical chemistry. B
Published: May 29, 2026
Annexin A6 Modulates the Secretion of Pro-Inflammatory Cytokines and Exosomes via Interaction with SNAP23 in Triple-Negative Breast Cancer Cells.
Journal: Cells
Published: May 07, 2026
Long-term cardiotoxicity outcomes of trastuzumab and cardiac safety of novel HER2-targeted therapies.
Journal: Expert opinion on drug safety
Published: May 04, 2026
Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration: a pan-cancer perspective.
Journal: Future science OA
Published: April 04, 2026
Vestibular schwannoma: genetic and epigenetic mechanisms, hearing loss, and emerging therapies.
Journal: Journal of neuro-oncology
Published: March 27, 2026
4-Anilinoquinazoline carbamate derivatization as a platform for prodrug design and localized drug delivery.
Journal: Bioorganic chemistry
Published: March 23, 2026
Identification of small-molecule inhibitors targeting HER2 for breast cancer therapy using structure-based virtual screening, ADMET profiling, and molecular dynamics simulations.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: March 16, 2026
Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 06, 2026
Identification and functional exploration of hub genes related to energy metabolism in acute myeloid leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 02, 2026
The association between anti-acid use and tyrosine kinase inhibitor-induced hepatotoxicity.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: February 16, 2026
Last Updated: 06/30/2026